A paper titled "Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses" was published on January 20th, 2022. The key findings of this paper suggest that CBD can be effective in preventing the SARS-CoV-2 from replicating once it has entered the cell. This video reviews those findings and talks about the data that was generated in order to come to these conclusions.
Cannabinoids and COVID: 2nd Paper Review
Join the Email List
Listen On
